Income Statement Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 10/12/2025 GMT			5-day change	1st Jan Change
92.70 ^USD	+0.18%		-5.96%	+3.78%

12-08	Why the Fed's Next Move Matters More Than Markets Admit
12-08	Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla…

89eaf36869400f51.LyGNRDnl0qiXgJAoh94IZVjwKFteufdZQ8rpBpVcnjQ.d3DALFrVp-Pd5Mp764E8IgeZbh8N7agjLf6FYqRk2kJFEsASVNKK583myQ

Published financial data: BOSTON SCIENTIFIC CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	9.91B	11.89B	12.68B	14.24B	16.75B
Total Revenues	9.91B	11.89B	12.68B	14.24B	16.75B
Cost of Goods Sold, Total	3.12B	3.65B	4B	4.39B	5.29B
Gross Profit	6.79B	8.24B	8.68B	9.85B	11.46B
Selling General & Admin Expenses, Total	3.74B	4.29B	4.52B	5.19B	5.98B
R&D Expenses	1.14B	1.2B	1.32B	1.41B	1.62B
Amortization of Goodwill and Intangible Assets - (IS)	789M	741M	803M	828M	856M
Other Operating Expenses, Total	5.66B	6.23B	6.65B	7.43B	8.46B
Operating Income	1.13B	2.01B	2.03B	2.42B	3B
Interest Expense, Total	-361M	-341M	-470M	-265M	-305M
Interest And Investment Income	3M	4M	10M	22M	107M
Net Interest Expenses	-358M	-337M	-460M	-243M	-198M
Currency Exchange Gains (Loss)	-32M	-27M	-31M	-41M	-16M
Other Non Operating Income (Expenses)	6M	-7M	-14M	-16M	-30M
EBT, Excl. Unusual Items	745M	1.64B	1.53B	2.12B	2.76B
Restructuring Charges	-298M	-191M	-24M	-69M	-16M
Merger & Related Restructuring Charges	-58M	-34M	-	-	-
Impairment of Goodwill	-73M	-	-	-	-
Gain (Loss) On Sale Of Investments	383M	250M	-1M	-59M	-79M
Gain (Loss) On Sale Of Assets	-	78M	-22M	-	-
Asset Writedown	-452M	-370M	-132M	-58M	-386M
Legal Settlements	-278M	-430M	-173M	111M	-
Other Unusual Items	-49M	136M	-35M	-58M	5M
EBT, Incl. Unusual Items	-80M	1.08B	1.14B	1.98B	2.28B
Income Tax Expense	2M	36M	443M	393M	436M
Earnings From Continuing Operations	-82M	1.04B	698M	1.59B	1.85B
Net Income to Company	-82M	1.04B	698M	1.59B	1.85B
Minority Interest	-	-	-	1M	8M
Net Income - (IS)	-82M	1.04B	698M	1.59B	1.85B
Preferred Dividend and Other Adjustments	33M	55M	56M	22M	1M
Net Income to Common Incl Extra Items	-115M	986M	642M	1.57B	1.85B
Net Income to Common Excl. Extra Items	-115M	986M	642M	1.57B	1.85B
Per Share Items
Net EPS - Basic	-0.08	0.69	0.45	1.08	1.26
Basic EPS - Continuing Operations	-0.08	0.69	0.45	1.08	1.26
Basic Weighted Average Shares Outstanding	1.42B	1.42B	1.43B	1.45B	1.47B
Net EPS - Diluted	-0.08	0.69	0.45	1.07	1.25
Diluted EPS - Continuing Operations	-0.08	0.69	0.45	1.07	1.25
Diluted Weighted Average Shares Outstanding	1.42B	1.43B	1.44B	1.46B	1.49B
Normalized Basic EPS	0.33	0.72	0.67	0.91	1.18
Normalized Diluted EPS	0.33	0.71	0.66	0.9	1.17
Payout Ratio	-34.15	5.28	7.88	1.76	-
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	2.25B	3.1B	3.17B	3.61B	4.27B
EBITA	1.92B	2.75B	2.84B	3.24B	3.86B
EBIT	1.13B	2.01B	2.03B	2.42B	3B
EBITDAR	2.34B	3.19B	3.26B	3.71B	4.37B
Effective Tax Rate - (Ratio)	-2.5	3.34	38.83	19.81	19.11
Current Domestic Taxes	-64M	51M	70M	204M	341M
Current Foreign Taxes	151M	127M	381M	116M	184M
Total Current Taxes	87M	178M	451M	320M	525M
Deferred Domestic Taxes	-32M	-259M	-124M	-104M	-183M
Deferred Foreign Taxes	-53M	117M	117M	176M	92M
Total Deferred Taxes	-85M	-142M	-7M	72M	-91M
Normalized Net Income	466M	1.02B	955M	1.32B	1.73B
Non-Cash Pension Expense	-	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.14B	1.2B	1.32B	1.41B	1.62B
Net Rental Expense, Total	92M	90M	91M	96M	98M
Imputed Operating Lease Interest Expense	26.62M	25.66M	36.27M	21.52M	23M
Imputed Operating Lease Depreciation	65.38M	64.34M	54.73M	74.48M	75M
Stock-Based Comp., COGS (Total)	9M	11M	12M	12M	14M
Stock-Based Comp., R&D Exp. (Total)	30M	36M	41M	42M	46M
Stock-Based Comp., SG&A Exp. (Total)	130M	147M	167M	179M	206M
Stock-Based Comp., Other (Total)	1M	-	-	-	-
Total Stock-Based Compensation	170M	194M	220M	233M	266M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.73B	1.92B	928M	865M	414M
Total Cash And Short Term Investments	1.73B	1.92B	928M	865M	414M
Accounts Receivable, Total	1.53B	1.78B	1.97B	2.23B	2.56B
Other Receivables	-	-	-	-	-
Total Receivables	1.53B	1.78B	1.97B	2.23B	2.56B
Inventory	1.35B	1.61B	1.87B	2.48B	2.81B
Prepaid Expenses	-	-	-	-	-
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	208M	188M	149M	130M	111M
Other Current Assets, Total	1.87B	816M	846M	807M	1.03B
Total Current Assets	6.69B	6.32B	5.76B	6.51B	6.92B
Gross Property Plant And Equipment	5.77B	5.96B	6.11B	6.78B	7.28B
Accumulated Depreciation	-3.22B	-3.27B	-3.28B	-3.48B	-3.53B
Net Property Plant And Equipment	2.54B	2.69B	2.83B	3.3B	3.74B
Long-term Investments	918M	412M	407M	413M	556M
Goodwill	9.95B	11.99B	12.92B	14.39B	17.09B
Other Intangibles, Total	6.14B	6.24B	5.97B	6.03B	6.68B
Deferred Tax Assets Long-Term	4.21B	4.14B	3.94B	3.84B	3.66B
Other Long-Term Assets, Total	327M	448M	639M	650M	748M
Total Assets	30.78B	32.23B	32.47B	35.14B	39.4B
Liabilities
Accounts Payable, Total	513M	794M	862M	942M	960M
Accrued Expenses, Total	1.67B	1.88B	1.86B	2.14B	2.53B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	13M	261M	20M	531M	1.78B
Current Portion of Leases	70M	71M	61M	76M	81M
Current Income Taxes Payable	158M	209M	232M	220M	268M
Unearned Revenue Current, Total	138M	208M	220M	266M	306M
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	1.12B	848M	553M	762M	473M
Total Current Liabilities	3.68B	4.27B	3.8B	4.93B	6.4B
Long-Term Debt	9.12B	8.8B	8.91B	8.57B	8.84B
Long-Term Leases	408M	395M	352M	395M	527M
Unearned Revenue Non Current	257M	276M	289M	311M	329M
Deferred Tax Liability Non Current	330M	310M	144M	134M	155M
Other Non Current Liabilities	1.65B	1.55B	1.4B	1.27B	1.14B
Total Liabilities	15.45B	15.61B	14.9B	15.61B	17.39B
Common Stock, Total	17M	17M	17M	17M	17M
Additional Paid In Capital	19.73B	19.99B	20.29B	20.65B	21.06B
Retained Earnings	-2.38B	-1.39B	-750M	819M	2.67B
Treasury Stock	-2.25B	-2.25B	-2.25B	-2.25B	-2.25B
Comprehensive Income and Other	206M	262M	268M	50M	275M
Total Common Equity	15.33B	16.62B	17.57B	19.28B	21.77B
Minority Interest	-	-	-	248M	233M
Total Equity	15.33B	16.62B	17.57B	19.53B	22B
Total Liabilities And Equity	30.78B	32.23B	32.47B	35.14B	39.4B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.42B	1.43B	1.43B	1.47B	1.48B
ECS Total Common Shares Outstanding	1.42B	1.43B	1.43B	1.47B	1.47B
Book Value / Share	10.82	11.66	12.26	13.16	14.76
Tangible Book Value	-760M	-1.6B	-1.32B	-1.14B	-2B
Tangible Book Value Per Share	-0.54	-1.12	-0.92	-0.78	-1.36
Total Debt	9.61B	9.52B	9.34B	9.57B	11.23B
Net Debt	7.88B	7.6B	8.42B	8.7B	10.81B
Debt Equivalent of Unfunded Proj. Benefit Obligation	176M	166M	106M	117M	127M
Debt Equivalent Oper. Leases	736M	720M	728M	768M	784M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	248M	233M
Equity Method Investments, Total	319M	259M	188M	219M	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	349M	452M	548M	773M	819M
Inventories - Work In Process, Total	109M	128M	147M	174M	193M
Inventories - Finished Goods, Total	893M	1.03B	1.17B	1.54B	1.8B
Land - (BS)	104M	109M	137M	140M	144M
Buildings, Total	1.29B	1.34B	1.7B	1.84B	2.02B
Machinery, Total	3.47B	3.48B	3.3B	3.5B	3.63B
Full Time Employees	38K	41K	45K	48K	53K
Accumulated Allowance for Doubtful Accounts (Supple)	105M	108M	109M	110M	109M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-82M	1.04B	698M	1.59B	1.85B
Depreciation & Amortization - CF	334M	352M	333M	368M	413M
Amortization of Goodwill and Intangible Assets - (CF)	789M	741M	803M	828M	856M
Depreciation & Amortization, Total	1.12B	1.09B	1.14B	1.2B	1.27B
(Gain) Loss From Sale Of Asset	-	-78M	22M	-	-
(Gain) Loss on Sale of Investments - (CF)	-398M	-250M	1M	59M	79M
Asset Writedown & Restructuring Costs	533M	370M	132M	58M	386M
Stock-Based Compensation (CF)	170M	194M	220M	233M	266M
Other Operating Activities, Total	120M	-149M	322M	135M	43M
Change In Accounts Receivable	335M	-279M	-220M	-238M	-351M
Change In Inventories	-65M	-346M	-321M	-660M	-228M
Change In Accounts Payable	88M	408M	-255M	118M	243M
Change in Other Net Operating Assets	-316M	-134M	-209M	10M	-126M
Cash from Operations	1.51B	1.87B	1.53B	2.5B	3.44B
Capital Expenditure	-376M	-554M	-588M	-711M	-790M
Sale of Property, Plant, and Equipment	12M	14M	12M	4M	3M
Cash Acquisitions	-3M	-2.26B	-1.54B	-1.81B	-4.64B
Divestitures	15M	826M	5M	-	-
Sale (Purchase) of Intangible assets	87M	82M	70M	30M	20M
Investment in Marketable and Equity Securities, Total	-146M	279M	-24M	-89M	-280M
Other Investing Activities, Total	-	14M	56M	3M	-
Cash from Investing	-411M	-1.6B	-2.01B	-2.57B	-5.69B
Short Term Debt Issued, Total	4.16B	-	-	-	211M
Long-Term Debt Issued, Total	1.68B	-	3.27B	-	2.14B
Total Debt Issued	5.84B	-	3.27B	-	2.36B
Short Term Debt Repaid, Total	-5.58B	-	-251M	-4M	-504M
Long-Term Debt Repaid, Total	-1.26B	-	-3.18B	-	-25M
Total Debt Repaid	-6.84B	-	-3.44B	-4M	-529M
Issuance of Common Stock	1.09B	110M	136M	182M	230M
Repurchase of Common Stock	-535M	-	-	-	-
Issuance of Preferred Stock	975M	-	-	-	-
Preferred Dividends Paid	-28M	-55M	-55M	-28M	-
Common & Preferred Stock Dividends Paid	-28M	-55M	-55M	-28M	-
Other Financing Activities, Total	-206M	-150M	-464M	-145M	-243M
Cash from Financing	293M	-95M	-548M	5M	1.81B
Foreign Exchange Rate Adjustments	-2M	-6M	-9M	-4M	-11M
Miscellaneous Cash Flow Adjustments	-	1M	-	-	-1M
Net Change in Cash	1.39B	173M	-1.04B	-70M	-450M
Supplemental Items
Cash Interest Paid	359M	338M	450M	259M	250M
Cash Income Tax Paid (Refund)	207M	302M	662M	512M	656M
Levered Free Cash Flow	1.22B	2.77B	1.15B	1.88B	1.81B
Unlevered Free Cash Flow	1.45B	2.98B	1.45B	2.05B	2B
Change In Net Working Capital	263M	-912M	660M	213M	643M
Net Debt Issued / Repaid	-999M	-	-165M	-4M	1.83B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.3	3.99	3.93	4.47	5.03
Return on Total Capital	2.87	4.92	4.79	5.39	6.02
Return On Equity %	-0.56	6.52	4.08	8.58	8.89
Return on Common Equity	-0.79	6.17	3.75	8.52	9.03
Margin Analysis
Gross Profit Margin %	68.53	69.32	68.44	69.16	68.41
SG&A Margin	37.69	36.06	35.64	36.45	35.73
EBITDA Margin %	22.72	26.09	24.99	25.37	25.5
EBITA Margin %	19.35	23.13	22.36	22.79	23.04
EBIT Margin %	11.39	16.9	16.03	16.97	17.93
Income From Continuing Operations Margin %	-0.83	8.76	5.5	11.17	11.02
Net Income Margin %	-0.83	8.76	5.5	11.18	11.07
Net Avail. For Common Margin %	-1.16	8.29	5.06	11.03	11.06
Normalized Net Income Margin	4.7	8.61	7.53	9.3	10.34
Levered Free Cash Flow Margin	12.32	23.3	9.11	13.2	10.79
Unlevered Free Cash Flow Margin	14.59	25.09	11.42	14.37	11.93
Asset Turnover
Asset Turnover	0.32	0.38	0.39	0.42	0.45
Fixed Assets Turnover	4	4.55	4.6	4.65	4.76
Receivables Turnover (Average Receivables)	5.9	7.19	6.77	6.78	7
Inventory Turnover (Average Inventory)	2.13	2.46	2.3	2.02	2
Short Term Liquidity
Current Ratio	1.82	1.48	1.51	1.32	1.08
Quick Ratio	0.89	0.87	0.76	0.63	0.46
Operating Cash Flow to Current Liabilities	0.41	0.44	0.4	0.51	0.54
Days Sales Outstanding (Average Receivables)	62.01	50.8	53.94	53.8	52.3
Days Outstanding Inventory (Average Inventory)	171.86	148.17	158.52	180.84	183.14
Average Days Payable Outstanding	66.76	61.07	70.94	65.74	61.98
Cash Conversion Cycle (Average Days)	167.11	137.9	141.51	168.9	173.46
Long Term Solvency
Total Debt/Equity	62.73	57.3	53.17	48.99	51.03
Total Debt / Total Capital	38.55	36.43	34.71	32.88	33.79
LT Debt/Equity	62.19	55.31	52.71	45.88	42.58
Long-Term Debt / Total Capital	38.22	35.16	34.41	30.8	28.19
Total Liabilities / Total Assets	50.2	48.43	45.88	44.42	44.15
EBIT / Interest Expense	3.13	5.89	4.33	9.12	9.84
EBITDA / Interest Expense	6.49	9.36	6.94	14	14.32
(EBITDA - Capex) / Interest Expense	5.45	7.74	5.69	11.31	11.73
Total Debt / EBITDA	4.1	2.98	2.87	2.58	2.57
Net Debt / EBITDA	3.36	2.38	2.58	2.35	2.48
Total Debt / (EBITDA - Capex)	4.89	3.61	3.5	3.19	3.14
Net Debt / (EBITDA - Capex)	4	2.88	3.15	2.9	3.02
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-7.66	19.92	6.68	12.29	17.61
Gross Profit, 1 Yr. Growth %	-10.99	21.32	6.78	13.48	16.33
EBITDA, 1 Yr. Growth %	-20.06	37.74	8.64	14.01	18.21
EBITA, 1 Yr. Growth %	-23.43	43.38	10.57	14.42	18.89
EBIT, 1 Yr. Growth %	-37.49	77.94	11.46	18.89	24.2
Earnings From Cont. Operations, 1 Yr. Growth %	-101.74	-1.37K	-32.95	127.94	15.95
Net Income, 1 Yr. Growth %	-101.74	-1.37K	-32.95	128.08	16.38
Normalized Net Income, 1 Yr. Growth %	-43.94	119.87	5.16	38.65	30.72
Diluted EPS Before Extra, 1 Yr. Growth %	-102.44	-950.03	-34.96	138.42	16.82
Accounts Receivable, 1 Yr. Growth %	-16.25	16.13	10.8	13.1	14.81
Inventory, 1 Yr. Growth %	-14.44	19.17	15.96	33.05	13.12
Net Property, Plant and Equip., 1 Yr. Growth %	5.26	5.7	5.4	16.45	13.49
Total Assets, 1 Yr. Growth %	0.69	4.72	0.74	8.21	12.12
Tangible Book Value, 1 Yr. Growth %	-83.17	110.66	-17.8	-13.53	80.78
Common Equity, 1 Yr. Growth %	10.44	8.46	5.72	9.73	12.9
Cash From Operations, 1 Yr. Growth %	-17.86	24.01	-18.4	64.02	37.24
Capital Expenditures, 1 Yr. Growth %	-18.44	47.34	6.14	20.92	11.11
Levered Free Cash Flow, 1 Yr. Growth %	-11.91	126.82	-56.48	62.79	-3.85
Unlevered Free Cash Flow, 1 Yr. Growth %	-13.98	106.18	-49.47	41.21	-2.32
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.46	5.23	13.11	9.45	14.91
Gross Profit, 2 Yr. CAGR %	-1.44	3.91	14.06	10.08	14.89
EBITDA, 2 Yr. CAGR %	-7.25	4.47	23.58	11.29	16.09
EBITA, 2 Yr. CAGR %	-9.13	4.26	27.63	12.48	16.63
EBIT, 2 Yr. CAGR %	-19.08	4.75	46.13	15.11	21.52
Earnings From Cont. Operations, 2 Yr. CAGR %	-77.85	-52.94	191.76	23.63	62.63
Net Income, 2 Yr. CAGR %	-77.85	-52.94	191.76	23.66	62.98
Normalized Net Income, 2 Yr. CAGR %	-29.17	9.99	64.02	20.75	34.66
Diluted EPS Before Extra, 2 Yr. CAGR %	-73.88	-54.48	135.13	24.53	66.89
Accounts Receivable, 2 Yr. CAGR %	-2.42	-1.38	13.43	11.94	13.95
Inventory, 2 Yr. CAGR %	7.64	0.98	17.56	24.21	22.68
Net Property, Plant and Equip., 2 Yr. CAGR %	19.44	5.48	5.55	10.79	14.96
Total Assets, 2 Yr. CAGR %	21.06	2.69	2.71	4.41	10.15
Tangible Book Value, 2 Yr. CAGR %	-63.02	-40.47	31.59	-15.69	23.37
Common Equity, 2 Yr. CAGR %	32.53	9.44	7.08	7.7	11.3
Cash From Operations, 2 Yr. CAGR %	120.56	0.92	0.6	15.69	50.03
Capital Expenditures, 2 Yr. CAGR %	9.08	9.62	25.05	13.29	15.91
Levered Free Cash Flow, 2 Yr. CAGR %	51.37	40.56	1.98	-15.83	25.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	45.48	32.56	4.13	-15.53	17.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.09	6.57	5.71	12.83	12.1
Gross Profit, 3 Yr. CAGR %	1.78	5.63	4.38	13.87	12.12
EBITDA, 3 Yr. CAGR %	-2.68	5.82	3.7	20.3	13.55
EBITA, 3 Yr. CAGR %	-3.94	5.79	3.88	23.07	14.58
EBIT, 3 Yr. CAGR %	-10.95	5.23	3.55	36.42	18.07
Earnings From Cont. Operations, 3 Yr. CAGR %	-7.62	-14.59	-47.04	168.71	21.04
Net Income, 3 Yr. CAGR %	-7.62	-14.59	-47.04	168.77	21.21
Normalized Net Income, 3 Yr. CAGR %	-17.73	3.32	4.11	55.08	24.01
Diluted EPS Before Extra, 3 Yr. CAGR %	2.26	-16.61	-48.73	136.22	21.9
Accounts Receivable, 3 Yr. CAGR %	-0.37	3.41	2.52	13.32	12.89
Inventory, 3 Yr. CAGR %	7.81	11.35	5.74	22.51	20.4
Net Property, Plant and Equip., 3 Yr. CAGR %	14.42	14.67	5.45	9.07	11.68
Total Assets, 3 Yr. CAGR %	17.36	15.35	2.03	4.51	6.92
Tangible Book Value, 3 Yr. CAGR %	-49.28	-33.95	-33.71	14.4	7.75
Common Equity, 3 Yr. CAGR %	29.78	23.96	8.19	7.95	9.41
Cash From Operations, 3 Yr. CAGR %	1.88	82.04	-5.98	18.4	22.47
Capital Expenditures, 3 Yr. CAGR %	5.63	20.58	8.45	23.66	12.56
Levered Free Cash Flow, 3 Yr. CAGR %	-0.73	73.22	-6.25	19.19	-12.01
Unlevered Free Cash Flow, 3 Yr. CAGR %	1.31	63.41	-5.15	15.26	-11.34
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.8	7.23	6.99	7.71	9.3
Gross Profit, 5 Yr. CAGR %	5.08	6.77	6.14	7.09	8.46
EBITDA, 5 Yr. CAGR %	4.02	7.06	5.34	6.65	8.49
EBITA, 5 Yr. CAGR %	3.98	7.27	5.56	6.91	8.8
EBIT, 5 Yr. CAGR %	0.84	7.63	4.92	6.99	10.39
Earnings From Cont. Operations, 5 Yr. CAGR %	-19.26	24.57	46.34	-0.98	-17.05
Net Income, 5 Yr. CAGR %	-19.26	24.57	46.34	-0.96	-16.98
Normalized Net Income, 5 Yr. CAGR %	-0.63	7.48	2.69	7.37	15.4
Diluted EPS Before Extra, 5 Yr. CAGR %	-14.72	22.51	42.68	-2.1	-17.8
Accounts Receivable, 5 Yr. CAGR %	3.73	3.85	4.94	6.74	6.95
Inventory, 5 Yr. CAGR %	5.86	11.01	11.61	16.33	12.22
Net Property, Plant and Equip., 5 Yr. CAGR %	11.28	10.51	10.79	13.1	9.16
Total Assets, 5 Yr. CAGR %	11.16	12.24	11.26	10.84	5.21
Tangible Book Value, 5 Yr. CAGR %	-34.59	-22.77	-25.73	-27.18	-15.01
Common Equity, 5 Yr. CAGR %	19.38	19.81	20.17	17.18	9.42
Cash From Operations, 5 Yr. CAGR %	16.89	9.61	1.36	51.85	13.35
Capital Expenditures, 5 Yr. CAGR %	8.77	8.06	13.01	17.61	11.37
Levered Free Cash Flow, 5 Yr. CAGR %	4.64	2.2	-1.54	28.68	5.22
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.68	2.55	0.81	24.51	3.32